MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.
MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.
复制标题
DOI:
10.1136/gutjnl-2013-306640
复制
发表时间:
2015-02
期刊:
影响因子:
24.5
通讯作者:
Yang HK
中科院分区:
文献类型:
--
作者:
Han TS;Hur K;Xu G;Choi B;Okugawa Y;Toiyama Y;Oshima H;Oshima M;Lee HJ;Kim VN;Chang AN;Goel A;Yang HK
Gastric cancer (GC) remains difficult to cure due to heterogeneity in a clinical challenge and the molecular mechanisms underlying this disease are complex and not completely understood. Accumulating evidence suggests that microRNAs (miRNAs) play an important role in GC, but the role of specific-miRNAs involved in this disease remains elusive. We performed next generation sequencing (NGS) based whole-transcriptome profiling to discover GC-specific miRNAs, followed by functional validation of results. NGS-based miRNA profiles were generated in matched pairs of GCs and adjacent normal mucosa (NM). Quantitative RT-PCR validation of miR-29c expression was performed in 274 gastric tissues, which included 2 cohorts of matched GC and NM specimens. Functional validation of miR-29c and its gene targets was undertaken in cell lines, as well as K19-C2mE and K19-Wnt1/C2mE transgenic mice. NGS analysis revealed four GC-specific miRNAs. Among these, miR-29c expression was significantly decreased in GC vs. NM tissues (P<0.001). Ectopic expression of miR-29c mimics in GC cell lines resulted in reduced proliferation, adhesion, invasion, and migration. High miR-29c expression suppressed xenograft tumor growth in nude mice. Direct interaction between miR-29c and its newly discovered target, ITGB1, was identified in cell lines and transgenic mice. MiR-29c expression demonstrated a step-wise decrease in wild type-hyperplasia-dysplasia cascade, in transgenic mice models of GC. MiR-29c acts as a tumor suppressor in GC by directly targeting ITGB1. Loss of miR-29c expression is an early event in the initiation of gastric carcinogenesis, and may serve as a diagnostic and therapeutic biomarker for patients with GC.
登录
查看更多内容
影响因子:
24.5
作者:
Hur K;Cejas P;Feliu J;Moreno-Rubio J;Burgos E;Boland CR;Goel A
通讯作者:
Goel A
影响因子:
37.3
作者:
Matsuo M;Nakada C;Tsukamoto Y;Noguchi T;Uchida T;Hijiya N;Matsuura K;Moriyama M
通讯作者:
Moriyama M
影响因子:
4.4
作者:
Li SC;Liao YL;Ho MR;Tsai KW;Lai CH;Lin WC
通讯作者:
Lin WC
影响因子:
11.2
作者:
Kim YH;Liang H;Liu X;Lee JS;Cho JY;Cheong JH;Kim H;Li M;Downey TJ;Dyer MD;Sun Y;Sun J;Beasley EM;Chung HC;Noh SH;Weinstein JN;Liu CG;Powis G
通讯作者:
Powis G
影响因子:
24.5
作者:
Hur K;Toiyama Y;Takahashi M;Balaguer F;Nagasaka T;Koike J;Hemmi H;Koi M;Boland CR;Goel A
通讯作者:
Goel A